Amgen’s $3.7 Billion Acquisition of ChemoCentryx

Wachtell, Lipton, Rosen & Katz represented Amgen, while Latham & Watkins represented ChemoCentryx in the transaction.Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally administered…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now